Ceporex Injectable, 180 mg/ml, suspension injectable
Ceporex Injectable, 180 mg/ml, suspension injectable
Authorised
- Cefalexin
Product identification
Medicine name:
Ceporex Injectable, 180 mg/ml, suspension injectable
Ceporex Injectie 180 mg/ml Injektionssuspension
Active substance:
- Cefalexin
Target species:
-
Cat
-
Dog
-
Cattle
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Cefalexin180.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cat
-
Dog
-
Cattle
-
Milkno withdrawal period0 days
-
Meat and offal19dayAnimals aimed for human consumption are not to be slaughtered during treatment
-
-
-
Subcutaneous use
-
Cat
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01DB01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Luxembourg
Package description:
- 1 x 100 ml Vial (glass type II) Suspension for injection
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet International GmbH
Responsible authority:
- Ministry Of Health
Authorisation number:
- V 817/95/07/0483
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 10/08/2023
Updated on: 11/08/2023
How useful was this page?:
